Global Molecular Diagnostics Market to be US$ 20.5 Billion by 2024
- 6 years ago
Access Full Research:
https://www.renub.com/global-molecular-diagnostics-market-opportunities-and-future-forecast-414-p.php
As per Renub Research analysis Global molecular diagnostics market is projected to become US$ 20.5 Billion opportunities by the year 2024, owing a significant growth during the forecast period. Some of the key factors that can be attributed to the growth of the molecular diagnostics market include rising prevalence of diseases, including cancers, growing awareness and acceptance of companion & personalized diagnostics and advancement in the molecular diagnostics techniques. Furthermore; rising incidence of neurological, cardiovascular and genetic disorders also helps molecular diagnostics market thrive in the coming years.
It is believed that development in molecular diagnostics has facilitated early detection of various diseases which possibly could result in major socioeconomic burden. According to WHO; the average prevalence of health care-associated infection varies between 3.5% and 12% in developed countries. While, the European Centre for Disease Prevention and Control reports an average prevalence of 7.1% in European countries. Molecular diagnostics plays a significant role in the diagnosis of infectious diseases as they provide effective results in no time.
Request a free sample copy of the report:
https://www.renub.com/contactus.php
Renub Research report titled “Molecular Diagnostics Market, Global Forecast by Application (Infectious Diseases, Blood Screening, Oncology, Genetic Testing, HLA (Tissue Typing), Microbiology, Cardiovascular Diseases, Neurological Diseases, Pharmacogenomics and Others), By Technology (PCR, Transcription-Mediated Amplification (TMA), Hybridiazation (In-situ Hybridiazation & FISH), DNA Sequencing & NGS, Microarray and Others), By End User (Hospitals & Academic Laboratories, Clinics and Commercial Laboratories, Others), By Regions [United States, Europe (Expect Russia), India, China, Japan, Brazil, South Korea, Mexico, Russia and ROW], Companies (Roche, Abbott, Myriad Genetics, Qiagen, BioMérieux and Others)” provides a complete analysis of Molecular Diagnostics Market.
By Application – Infectious Disease Testing holds the Maximum Market Share
The report studies the market of the following Diagnostics segments: Infectious Diseases, Blood Screening, Oncology, Genetic Testing, HLA (Tissue Typing), Microbiology, Cardiovascular Diseases, Neurological Diseases, Pharmacogenomics and Others.
By Technology – PCR Segment is leading the market and will continue so during the Forecast period
On the basis of technology, the molecular diagnostics market has been broadly segmented into PCR, Transcription-Mediated Amplification (TMA), Hybridiazation (In-situ Hybridiazation & FISH), DNA Sequencing & NGS, Microarray and Others.
By End User – Hospitals & Academic Laboratory holds the Largest Market
https://www.renub.com/global-molecular-diagnostics-market-opportunities-and-future-forecast-414-p.php
As per Renub Research analysis Global molecular diagnostics market is projected to become US$ 20.5 Billion opportunities by the year 2024, owing a significant growth during the forecast period. Some of the key factors that can be attributed to the growth of the molecular diagnostics market include rising prevalence of diseases, including cancers, growing awareness and acceptance of companion & personalized diagnostics and advancement in the molecular diagnostics techniques. Furthermore; rising incidence of neurological, cardiovascular and genetic disorders also helps molecular diagnostics market thrive in the coming years.
It is believed that development in molecular diagnostics has facilitated early detection of various diseases which possibly could result in major socioeconomic burden. According to WHO; the average prevalence of health care-associated infection varies between 3.5% and 12% in developed countries. While, the European Centre for Disease Prevention and Control reports an average prevalence of 7.1% in European countries. Molecular diagnostics plays a significant role in the diagnosis of infectious diseases as they provide effective results in no time.
Request a free sample copy of the report:
https://www.renub.com/contactus.php
Renub Research report titled “Molecular Diagnostics Market, Global Forecast by Application (Infectious Diseases, Blood Screening, Oncology, Genetic Testing, HLA (Tissue Typing), Microbiology, Cardiovascular Diseases, Neurological Diseases, Pharmacogenomics and Others), By Technology (PCR, Transcription-Mediated Amplification (TMA), Hybridiazation (In-situ Hybridiazation & FISH), DNA Sequencing & NGS, Microarray and Others), By End User (Hospitals & Academic Laboratories, Clinics and Commercial Laboratories, Others), By Regions [United States, Europe (Expect Russia), India, China, Japan, Brazil, South Korea, Mexico, Russia and ROW], Companies (Roche, Abbott, Myriad Genetics, Qiagen, BioMérieux and Others)” provides a complete analysis of Molecular Diagnostics Market.
By Application – Infectious Disease Testing holds the Maximum Market Share
The report studies the market of the following Diagnostics segments: Infectious Diseases, Blood Screening, Oncology, Genetic Testing, HLA (Tissue Typing), Microbiology, Cardiovascular Diseases, Neurological Diseases, Pharmacogenomics and Others.
By Technology – PCR Segment is leading the market and will continue so during the Forecast period
On the basis of technology, the molecular diagnostics market has been broadly segmented into PCR, Transcription-Mediated Amplification (TMA), Hybridiazation (In-situ Hybridiazation & FISH), DNA Sequencing & NGS, Microarray and Others.
By End User – Hospitals & Academic Laboratory holds the Largest Market